15
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Increased Susceptibility of the Left Compared to the Right Ventricle to Remote Ischemia/Reperfusion Injury in Human C1-Inhibitor-Overexpressing Transgene Mice

, , , , , & show all
Pages 281-286 | Published online: 09 Jul 2009

  • Crawford MH, Graver ML, KoIb WP, McMahan A, O'Rourke RA, McManus LM, Pinckard RN. Complement and neutraphil activation in the pathogenes!s of ischemie myocardial injury. Circulation. 1988;78:144-148.
  • Seeger W, Suttorp N, Hellwig A, Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J lmmunol. 1986; 137:12861293.
  • Hattori R, Hamilton KK, McEver RP, Sims PJ. Complement protein C5b-9 induces secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem. 1989;264:9053-9060.
  • Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA. C5ainduced expression of P-selectin in endothelial cells. J Clin Invest. 1994;94:1147-1155.
  • Shandelya SML, Kuppusamy P, Herskowitz A, Weisfeldt ML, Zweier JL. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Circulation. 1993;88:2812-2826.
  • Weisman HF, Bartow T, Leppo MK, Marsh HC, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT. Soluble complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 1991:249:146-151.
  • Buerke M, Murohara T, Lefer AM. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation. 1995;91:393-402.
  • Horstick G, Heimann A, Gotze O, Hafner G, Berg O, Boehmer P, Becker P, Darius H, Rupprecht HJ, Loos M, Bhakdi S, Meyer J, Kempski O. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation. 1997;95:701-708.
  • Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moore FD. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemiareperfusion in the rat. J lmmunol. 1992;149:1723-1728.
  • Nuijens JH, Huijbregts CCM, Mierlo GM, van Hack CE. Inactivation of C1 inhibitor by proteases: Demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-complexed C1 inhibitor. Immunology. 1987;61:387-389.
  • Trevi GP, Sheiban I. Chronic ischaemic (hibernating) and postischaemic (stunned) dysfunctional but viable myocardium. Eur Heart J. 1991;12(suppl G):G20-G26.
  • BoIIi R, Jeroudi MO, Patel BS, Aruoma Ol, Halliwell B, Lai EK, McCay P. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at time of reperfusion. Circ Res. 1989;65:607-622.
  • Lefer AM, Tsao PS, Lefer DJ, Ma X-L. Role of endothelial dysfunction i n the pathogenesi s of reperfusion injury after myocardial ischemia. FASEB J. 1991;5:2029-5034.
  • Ma X-L, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72:403-412.
  • Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol. 1993;33:71-90.
  • Buerke M, Prüfer D, Dahm M, Oelert H, Meyer J, Darius H. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemie myocardium from reperfusion injury. J Pharmacol Exp Ther. 1998;286:429-438.
  • Leeman M,Van Cutsem M,VachieryJL, Antoine M, Ledere JL. Determinants of right ventricular failure after heart transplantation. Acta Cardiol. 1996;51:441-449.
  • Whitehead B, James I, Helms P, Scott JP, Smyth R, Higenbottam TW, McGoldrick J, English TA, Wallwork J, Elliott M. Intensive care management of children following heart and heart-lung transplantation. Inters Care Med. 1990;16:426-430.
  • Klima U, Kutschka I, Warnecke G, Kim P, Strüber M, Kirschfink M, Haverich A. Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation model. Eur J Cardiothorac Surg. 2000; 18:321-327.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.